Plaquenil Retinotoxicity

Larry J Alexander OD FAAO Sunday, 19 January 2014

EYELESSONS.COM Disclaimer: The content provided herein is for educational and informational purposes only; nothing provided herein should be intended to create a physician-patient relationship or an offer for a contract and does not constitute medical diagnosis or advice. The opinion relating to a review of any issue presented or discussed is the sole responsibility of the healthcare provider or medical advisor. The doctor or patient must assume all liability, including, but not limited to, any direct, indirect, incidental, consequential, or any other monetary or other damages, or liabilities arising out of or relating in any way to the content  or information provided herein.

49 yo

  - ROUTINE PLAQUENIL CHECK

  - HX SLE AND ASSOCIATED LIVER DYSFUNCTION

  - HX OF DRY EYES MEDS INCLUDE: NAPROXEN, AND PLAQUENIL 200 MG QD X 2 YEARS- CUMULATIVE DOSE 146,000 MG

  - BCVA 20/20 OU

EYELESSONS.COM Disclaimer: The content provided herein is for educational and informational purposes only; nothing provided herein should be intended to create a physician-patient relationship or an offer for a contract and does not constitute medical diagnosis or advice. The opinion relating to a review of any issue presented or discussed is the sole responsibility of the healthcare provider or medical advisor. The doctor or patient must assume all liability, including, but not limited to, any direct, indirect, incidental, consequential, or any other monetary or other damages, or liabilities arising out of or relating in any way to the content  or information provided herein. 

Slide4Slide5Slide6Slide7Slide8Slide9Slide10Slide11Slide12Slide13Slide14

Caveat: When using any guidelines one must consider correlation with other patient characteristics and other clinical tests such as but not limited to: chief complaint, age, gender, ethnicity, refractive status, family history, associated medical conditions, current medications, pachymetry, visual field testing, angle assessment.

Related Articles

Macular Ganglion Cell Loss In Ocular Disorders
Plaquenil Letter to GPs
Plaquenil Retinotoxicity Updated Guidelines
So You Think Checking For Plaquenil Toxicity Will Not Make A Difference?

About the Author(s)

Larry J Alexander OD FAAO

Larry J Alexander OD FAAO

Dr. Alexander (1948-2016) was a 1971 graduate of Indiana University School of Optometry. He served in the US Navy then served as a Professor at the University of Alabama Birmingham School of Optometry. Larry contributed to a number of chapters in textbooks and has published three editions of Primary Care of the Posterior Segment, as well as contributed to the professional literature. He also lectured extensively in the area of ocular and systemic disease. His areas of special interest included dysfunctional tear syndrome, glaucoma and macular degeneration.  His lessons are the basis for this site and he will be dearly missed. 

Leave a comment

You are commenting as guest. Optional login below.